Infections of the upper respiratory tract and skin due to group A Streptococcus are common, and the organism is highly transmissible. In industrialized countries and to some extent in developing countries, control efforts continue to emphasize that group A streptococcal pharyngitis should be properly diagnosed and appropriately treated. In developing countries and in indigenous populations where the burden of group A streptococcal diseases appears greatest, the epidemiology is less completely defined and may differ from that in industrialized countries. There is a need for accurately collected epidemiological data from developing countries, which may also further clarify the pathogenesis of group A streptococcal infections and their sequelae. While proper treatment of group A streptococcal pharyngitis continues to be essential in all populations, it may be appropriate in developing countries to consider additional strategies to reduce rates of pyoderma.
The spectrum of diseases caused by group A b-hemolytic matic fever in many developing countries are at levels similar to those seen in industrialized countries 50 -100 years ago [1, Streptococcus is broad, ranging from simple and uncomplicated pharyngitis and pyoderma to severe invasive infections and the 4]. High levels of exposure to group A streptococci throughout childhood as a result of influences such as overcrowded houspoststreptococcal nonsuppurative sequelae of acute rheumatic fever and acute glomerulonephritis. During the 20th century ing, limited access to medical services, and inadequate environmental hygiene and sanitation may explain a substantial proporthe more severe consequences of group A streptococcal infections have become relatively uncommon in industrialized countion of the apparently increased rates of group A streptococcal diseases in developing countries. tries, but the incidence of group A streptococcal pharyngitis has not decreased. The beginning of this decline in sequelae preceded the availability of antibiotics and was attributed mainly to improvements in standards of living [1, 2] . Since the Epidemiology in Industrialized Countries 1940s, further reductions in the incidence of these infections Current understanding of the epidemiology of group A strephave been thought to have been influenced (but not fully extococcal infections comes largely from studies in industrialized plained) by more accurate diagnosis of streptococcal infections, countries, where pharyngitis and tonsillitis are very common perhaps combined with the availability of specific antimicrobial in children aged 5 -15 years, whereas streptococcal pyoderma therapy; both have been temporally related to improved access is less common and mostly seen in children aged õ5 years. to health care [3] .
Dingle and colleagues found that in families followed prospecBy contrast, the impact of serious group A streptococcal tively for extended periods, the average child had experienced diseases in many developing and even indigenous populations one group A streptococcal upper respiratory tract infection by in industrialized countries is much greater. Rates of acute rheu-5 years of age [5] . By 13 years of age, the average was 3 documented episodes per child; the range was from 1 to 8 distinct group A streptococcal infections during that period. Group A streptococci are highly transmissible, and their patThis article is part of a series of papers presented at a symposium entitled ''International Conference on Acute Respiratory Infections'' that was held 7 -tern of spread in families and communities is dynamic; predom- Although penicillin has been the antibiotic of choice to treat group A streptococcal infections for ú50 years, to date there has never been a clinical isolate of group A Streptococcus that is resistant to penicillin. Although much has been written about Force Base in Wyoming. Acquisition rates were related to the distance of beds from the nearest ''colonized'' barracks mate tolerance to penicillin, this has not been shown conclusively to be of clinical significance. Resistance to the sulfa drugs and ranged from ú60 acquisitions per 100,000 man-weeks when the distance was between 0 and 5 feet to õ20 per 1,000
and tetracyclines quickly became a problem following their introduction into clinical practice. The only other group of man-weeks when the distance was §30 feet [8] . This example of ''crowding'' is important when considering the epidemiolantibiotics to which resistance has developed to any important level has been the macrolides [18]. This was a major problem ogy of group A streptococcal respiratory tract infections in socially and economically disadvantaged populations.
in Japan in the 1960s and 1970s, and recently has been shown to be a problem in some European countries [19] . However, Although environmental factors such as crowding certainly contribute to the risk of acquisition of group A Streptococcus in most parts of the world the macrolides remain clinically effective for treatment of group A streptococcal upper respiraand the development of subsequent suppurative or nonsuppurative complications, they are clearly not the sole determinants.
tory tract infections in individuals who are allergic to penicillin. In studies carried out during 2 decades in Rochester, New York, Hall [9] clearly documented that while the incidence of Epidemiology of Group A Streptococcal Infections and streptococcal sore throats remained relatively constant (with Their Sequelae in Developing Countries expected yearly fluctuations), the incidence of acute rheumatic fever and acute poststreptococcal glomerulonephritis fell preUnlike in industrialized countries, few comprehensive and prospective studies have been carried out in developing councipitously. Outbreaks of acute rheumatic fever in the United States during the latter part of the 1980s and early 1990s octries to clarify the epidemiology of group A streptococcal infections in these populations. However, the data that are available curred in middle-class populations with ready access to medical care [10] . These outbreaks were attributed to the concomitant suggest that some of the basic epidemiological features of group A streptococcal diseases in developing countries may appearance of mucoid strains of group A Streptococcus in the upper respiratory tracts of children in that community [11] and differ from those in better-studied, more affluent populations. For example, epidemics of acute rheumatic fever occur in miliwere associated most frequently with strains of M serotypes 1, 3, 5, 6, and 18 [12] . These observations cannot be fully extary populations and in the wider community in the United States [10, 20], but epidemics have rarely, if ever, been reported plained by social and economic factors and suggest that the introduction into a population of certain strains with a capacity from developing countries. This does not mean that they do / 9c61$$fe26 01-22-99 12:13:50 cida UC: CID not occur; it may reflect the inadequacy of epidemiological to cause acute rheumatic fever (either de novo or acquired by horizontal transfer of genetic material, as appears to occur in studies in these countries.
The dynamics of streptococcal acquisition may also vary in some strains [30] ) and that they lead to rheumatic fever, either directly by skin infection or by subsequently infecting the different environments. Classic descriptions of the transmission and endemicity of group A streptococcal infections in industrithroats of children. This latter possibility would seem unlikely in light of data published by Bisno and colleagues suggesting alized countries with temperate climates rely primarily on the concept of pharyngeal infection, carriage, and droplet spread that so-called skin strains do not cause acute rheumatic fever when isolated from the throats of rheumatics [31] . However, [21] . An encounter with a potentially infecting strain of group A Streptococcus may be relatively uncommon [22, 23] . This in New Zealand, where high incidence rates of acute rheumatic fever are found in the Maori and Pacific Islander populations contrasts with the situation in developing countries and/or other indigenous populations in tropical climates; where pyoderma [32] , group A streptococcal isolates recovered from the throats of patients with rheumatic fever belonged largely to serotypes is prevalent, the majority of children in a community may be infected with group A streptococci at any one time, and multiassociated with skin rather than throat infection in that population [33] . Moreover, during a recent 4-year period in Tunisia, ple different strains of group A streptococci may be circulating in the community [6] . Multiple strains may even be isolated more M-typable strains of group A streptococci from throats of patients with acute rheumatic fever came from known pyofrom the same individual [24] . Further observations in some of these populations raise questions about the nature of the derma-associated and nephritis-associated serotypes (M types 2, 9, 11, 33, and 49) than from known rheumatic fever -associprimary streptococcal infections leading to rheumatic fever.
For example, in aboriginal communities of northern Austraated serotypes [34] .
Others have found isolates of M serotypes conventionally lia, where the highest published incidence of acute rheumatic fever in the world has been reported [25] , the prevalence of associated with pyoderma in the throats of patients with rheumatic fever [35, 36] . A case of acute rheumatic fever has been pyoderma (commonly secondary to scabies infestation) among children may be §70% throughout the year [26] . These childescribed following group A streptococcal infection of an infected wound with a T-agglutination pattern (T3/13/B3264) dren often harbor multiple, different serotypes of group A Streptococcus in their lesions [27] . Individual communities that is commonly associated with pyoderma and has been associated with rheumatic fever elsewhere [37, 38] . With newer have up to 14 genetically different group A streptococcal strains circulating at any one time [28] . Yet in these communities, molecular techniques available for typing strains of group A Streptococcus, more data can now be obtained to clarify this throat-carriage rates for group A Streptococcus are consistently õ5% and often õ2% [26] . possibility. A third possibility is raised by a hypothesis less related to The incidence rates of bona fide group A streptococcal pharyngitis in these communities are not precisely defined, although a specific site of infection. It suggests that the peculiar age distribution of patients with acute rheumatic fever can be exanecdotal reports suggest that in some remote communities presentations with sore throat are not as common as in urban plained by the necessity for ''priming'' the immune system by repeated group A streptococcal infections [23]; this would be settings. Thus, in Australian aboriginal communities with high rates of pyoderma, the primary source of group A streptococcal compatible with multiple episodes of streptococcal pyoderma during early childhood. infection and transmission may not be the throat; the skin sores of children (and many adults) could contribute substantially to
Aside from generally higher rates of pyoderma and impetigo, there are other aspects of group A streptococcal pharyngeal community spread.
Such observations raise the intriguing question of how this infection that may differ between developing and industrialized countries. Markowitz, among others, has noted that data from apparently low prevalence of group A streptococci in the upper respiratory tract and a high incidence of pyoderma can be some developing countries indicate that a lower percentage of children with pharyngitis have throat cultures positive for group correlated with high rates of acute rheumatic fever in the same communities, in light of the generally accepted dogma that A Streptococcus than in the United States [39] . There is also evidence that group A streptococcal pharyngitis is more often acute rheumatic fever follows only group A streptococcal infection of the throat, not of the skin [29] . There are a number of mild or subclinical in developing countries. A 3-year prospective study in Egypt found no occurrences of typical exudative theoretical possibilities that require consideration. Perhaps the low throat-carriage rates of group A streptococci in this populapharyngitis, despite group A streptococcal pharyngitis attack rates (determined by culture and immune response) equivalent tion do not reflect the true incidence of group A streptococcal pharyngitis (either symptomatic or asymptomatic) and, as gento those found in North American studies [40] . Another prospective study in India found that, of 53 children with group erally accepted, the group A streptococcal strains associated with pyoderma lesions play no role in acute rheumatic fever A streptococci isolated from the pharynx, 54% had serological evidence of infection, yet none had manifested symptoms or pathogenesis.
A second possibility is that some group A streptococcal signs of pharyngitis [16] . Asymptomatic infection due to group A Streptococcus is well described and may be common in strains isolated from pyoderma lesions may have the potential / 9c61$$fe26 In tropical regions, throat-isolation rates of groups C and G the 1970s, but it is likely that medical services improved, as this program coincided with the establishment of a national streptococci are higher than those for group A [1, 39] . Groups C and G streptococci can cause invasive disease and pharyngitis health plan. Improved quality and availability of medical care have been shown elsewhere to result in reduced rates of acute [41] . Group C Streptococcus can cause acute poststreptococcal glomerulonephritis [42] . Both may express M protein [43, 44] , rheumatic fever [59] . A more comprehensive acute rheumatic fever control proand there is evidence of horizontal M-protein gene transfer between group A and group G Streptococcus [45, 46] . It is gram in the French Caribbean involved the establishment of a register for acute rheumatic fever/rheumatic heart disease and unclear whether these other serogroups of b-hemolytic streptococci may alter the epidemiology and recovery of group A an extensive education campaign about the nature and treatment of primary group A streptococcal infections, including both streptococci or to what extent they may have the potential to cause suppurative or nonsuppurative complications. More data pharyngitis and pyoderma [60] . The consequent reduction in incidence of acute rheumatic fever was impressive and offers from both laboratory and clinical studies are needed.
hope that group A streptococcal control programs can be effective without specifically addressing poverty and living condiPrevention tions. However, it also suggests that until additional studies have clarified the relative importance of throat and skin infecPublic health programs for control of group A Streptococcus in developing countries have tended to focus on the establishtions in the pathogenesis of acute rheumatic fever in these regions, prevention programs may need to address all group A ment of registers for acute rheumatic fever/rheumatic heart disease and on improvement of compliance for those receiving streptococcal infections, not only those of the upper respiratory tract. secondary prophylaxis regimens [3, 4, 47, 48] . This has represented a major step forward in control of acute rheumatic fever and rheumatic heart disease but has done little to reduce the The Future: Research and Prevention incidence of first attacks of rheumatic fever or the overall number of people requiring secondary prophylaxis [3] . The
There is a clear need for well-planned, prospective, longitudinal studies to understand more completely the epidemiology lack of implementation of primary prevention of rheumatic fever in the developing world has occurred for a number of of group A Streptococcus in developing countries and to implement more effective public health prevention programs. The reasons. These include the lack of financial and medical resources, the scarcity of laboratory facilities necessary to reduce problem of the inability to M-serotype many isolates from regions of endemicity [61, 62] is being addressed by employing the overuse of penicillin and other antibiotics (in the absence of proper diagnosis), and difficulties with providing adequate molecular techniques (e.g., PCR) for typing systems [28, 63] . The existing network of streptococcal reference laboratories professional education for health care workers.
Approaches to primary prevention of acute rheumatic fever could make these techniques available to researchers in developing countries by typing isolates collected during properly in industrialized countries have varied [49] and have included mass antibiotic prophylaxis in military populations [50] and planned, prospective studies, helping with data analysis, and possibly assisting in the training of laboratory personnel in various combinations of screening surveillance of children with sore throats [51 -53] . Public health prevention programs in those countries. This could be part of an international effort to standardize new approaches to typing in the same way that M indigenous populations in industrialized countries have resulted in some success. However, these have also been accused of typing is standardized; at present a number of different molecular techniques are used, and it is often difficult to compare not being cost-effective [54] and resulting in the overuse of penicillin [55] . A program in an Australian aboriginal commuresults between laboratories, even when the same technique is used. Furthermore, there is the distinct need to correlate molecnity that involved screening with use of throat swabs, in combination with penicillin treatment of group A streptococcal carriular features with the biological properties of specific serotypes that have been classified by conventional serological techers, could not be sustained over the long term [56, 57] .
Two recent examples from developing countries illustrate the niques. There is also a need for continuing laboratory research to complexity of primary prevention programs, especially where epidemiological data are incomplete. A policy of empirically better understand the pathogenesis of acute rheumatic fever and acute poststreptococcal glomerulonephritis. This is essential treating all sore throats in children with intramuscular penicillin G benzathine, introduced in Costa Rica during the 1970s, was to the development of a cost-effective group A streptococcal vaccine(s). Additional information about the significance of a temporally associated with a reduction in the incidence of acute rheumatic fever [58] . However, the major part of the decline genetic marker for determining susceptibility to acute rheu- Further definitive recommendations about primary preven-
